Publicaciones en colaboración con investigadores/as de Universidad de Navarra (8)

2023

  1. Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

    Haematologica, Vol. 108, Núm. 10, pp. 2753-2763

2022

  1. Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 9, pp. e844-e852

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420

1991

  1. Protection against the lethal effect and arthritogenic capacity of Yersinia enterocolitica serovar O: 3 for mice

    FEMS Microbiology Letters, Vol. 76, Núm. 5, pp. 289-297

1986

  1. Analysis by coagglutination of the distribution of a 24,000-dalton surface protein in Yersinia isolates

    Journal of Clinical Microbiology, Vol. 23, Núm. 4, pp. 804-805

1985

  1. Characterization of a Yersinia enterocolitica antigen common to enterocolitis-associated serotypes

    Journal of Clinical Microbiology, Vol. 22, Núm. 6, pp. 1035-1039

1982

  1. Immunological identity of Brucella native hapten, polysaccharide B, and Yersinia enterocolitica serotype 9 native hapten

    Infection and Immunity, Vol. 38, Núm. 2, pp. 778-780